NME1 and ductal breast carcinoma in situ: NME expression was investigated by IHC analysis on whole sections and on a tissue microarray (TMA) of synchronous DCIS and IBC foci from 156 breast cancer patient samples using specific NME1 pAb and NME2 mAb with no cross-reactivity (Supplementary Fig. S1 and Table S2).